Medical Devices Singapore

Singapore Myopia Control Market Analysis, 2024–2034

Updated Reviewed by Vidhi Upadhyay

Singapore Myopia Control Market Industry Trends and Forecast to 2034: Segmented by (Product, Age, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

Singapore · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $4.7 Mn Placeholder estimate
Estimate 2025 $5.5 Mn 0.1% of the global market
Projected 2034 $20.2 Mn 268.7% Adds $14.7 Mn over 9 forecast years
CAGR 2025–2034 15.6% Faster than 86% of 173 Medical Devices markets here
Key players 5
  • Singapore is 0.14% of the global market.
  • In APAC, the largest is China at $284.4 Mn.
  • Fastest growing: India at 18.2% a year.
  • Singapore ranks 9th of 10 by size in APAC.

Market size projection

Singapore

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$14.7 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Myopia Control Market market size by year, Singapore
YearMarket sizeChange that yearSince 2025
2024 (estimate) $4.7 Mn — —
2025 (base) $5.5 Mn +$0.7 Mn —
2026 (forecast) $6.3 Mn +$0.9 Mn +15.6%
2027 (forecast) $7.3 Mn +$1.0 Mn +33.6%
2028 (forecast) $8.5 Mn +$1.1 Mn +54.5%
2029 (forecast) $9.8 Mn +$1.3 Mn +78.6%
2030 (forecast) $11.3 Mn +$1.5 Mn +106.4%
2031 (forecast) $13.1 Mn +$1.8 Mn +138.6%
2032 (forecast) $15.1 Mn +$2.0 Mn +175.9%
2033 (forecast) $17.5 Mn +$2.4 Mn +218.9%
2034 (forecast) $20.2 Mn +$2.7 Mn +268.7%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Same market worldwide

By geography

  1. Global $3.97 Bn
  2. North America $2.04 Bn
  3. US $1.84 Bn
  4. APAC $770.5 Mn
  5. Europe $637.6 Mn
  6. Canada $305.9 Mn
  7. China $284.4 Mn
  8. Japan $237.9 Mn
  9. Latin America $203.0 Mn
  10. Middle East $172.0 Mn
  11. Germany $132.2 Mn
  12. UK $107.2 Mn
  13. Brazil $103.7 Mn
  14. France $95.8 Mn
  15. Italy $81.8 Mn
  16. Spain $80.3 Mn
  17. Ecuador $77.5 Mn
  18. India $70.0 Mn
  19. Saudi Arabia $60.2 Mn
  20. Mexico $58.9 Mn
  21. Africa $53.6 Mn
  22. New Zealand $43.0 Mn
  23. Australia $42.2 Mn
  24. Russia $40.1 Mn
  25. South Africa $28.0 Mn
  26. UAE $17.7 Mn
  27. Philippines $10.0 Mn
  28. Egypt $9.9 Mn
  29. Malaysia $6.9 Mn
  30. Hong Kong $6.3 Mn
  31. Singapore (this report) $5.5 Mn
  32. Thailand $5.2 Mn
  33. Kenya $2.8 Mn

Report snapshot

Singapore Myopia Control Market Analysis at a glance
Market size, 2025$5.5 Mn placeholder estimate
Forecast, 2034$20.2 Mn placeholder estimate
Growth (CAGR), 2025–203415.6% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsProduct, age and end user (see all)
Key playersEssilorLuxottica, HOYA, CooperVision, Johnson & Johnson, Santen Pharmaceutical Co Ltd (see all)
Regulator in SingaporeHSASource: Health Sciences Authority. Checked 14 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The Singapore Myopia Control Market Analysis Executive Summary

Myopia control slows short-sightedness getting worse in children, using special glasses, contact lenses and eye drops.

Key segments of the myopia Control market include product (Myopia Control Spectacle Lenses, Orthokeratology Lenses and Soft Multifocal Contact Lenses) and age (Children and Teenagers).

Bar chart: Singapore Myopia Control market size, 2024–2034, placeholder estimates. $4.7 Mn in 2024, $5.5 Mn in 2025 and $20.2 Mn in 2034, 15.6% CAGR.
Singapore Myopia Control market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

Singapore Myopia Control Market Dynamics

Market Growth Drivers

An ageing population, more people with diabetes and long-term conditions, better treatments and wider access to specialist care are driving the myopia Control market.

Opportunity

Longer-acting treatments, home-based care and screening in emerging markets give the myopia Control market room to grow.

Market Restraints

High costs of new treatments, specialist shortages, low awareness and limited reimbursement in some countries hold back the myopia Control market.

Competitive Landscape for Myopia Control Market in Singapore

The myopia Control market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Myopia Control Market in Singapore

Myopia Control in Singapore: rules and payment

Medical devices must be registered with the Health Sciences Authority (HSA), except low-risk Class A devices.⁠[1] MediShield Life gives basic health insurance to all citizens and permanent residents, alongside MediSave savings accounts.⁠[2]

[1] Health Sciences Authority. Checked 14 Nov 2026.

[2] CPF Board, MediShield Life. Checked 14 Nov 2026.

Policy changes and Reimbursement scenario

Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how myopia Control products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in Singapore.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Myopia Control right now, from free public sources.

Latest research 1,160 papers since 2021 (worldwide)

  1. Normal corneal endothelial development is preserved during pediatric daily disposable omafilcon A soft contact lens wear. Optometry and vision science : official publication of the American Academy of Optometry, 2026
  2. Perceived Challenges, Barriers, and Strategies for Orthokeratology Practice: Insights From Eye Care Practitioners in India. Eye & contact lens, 2026
  3. Efficacy and safety of repeated low-level red light therapy in myopia control: an updated and comprehensive systematic review and meta-analysis. BMC ophthalmology, 2026
  4. Inter-Racial Differences in Axial Length of Young Singaporean Males. Ophthalmic epidemiology, 2026
  5. [Multisegment spectacles for prevention of myopia progression]. Die Ophthalmologie, 2026
Search all of them on PubMed (opens in a new tab)

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Myopia Control in context

Singapore compared

  • Health spending per person: 3,922 US$ per person (2023). World: 1,317 US$ per person (2023). 3rd highest of the 15 countries we cover in APAC.[1]
  • Doctors: 2.83 per 1,000 people (2022). World: 1.86 per 1,000 people (2022). 4th highest of the 15 countries we cover in APAC.[2]
  • People aged 65 and over: 14.2% of people (2025). World: 10.4% of people (2025). 7th highest of the 16 countries we cover in APAC.[3]

[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 14 Nov 2026.

[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 14 Nov 2026.

[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 15 Nov 2026.

Free data on this topic

Quick answers

Frequently asked questions

How big is the Myopia Control market in Singapore?
Placeholder estimate: about $5.5 Mn in 2025, rising to about $20.2 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Myopia Control market in Singapore growing?
Placeholder estimate: about 15.6% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Myopia Control market report cover?
The report splits the market by product (Myopia Control Spectacle Lenses, Orthokeratology Lenses, Soft Multifocal Contact Lenses, Low-Dose Atropine), age (Children, Teenagers) and end user (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Home Care Settings).
Who are the key players in the Myopia Control market?
Key players include EssilorLuxottica, HOYA, CooperVision, Johnson & Johnson and Santen Pharmaceutical Co Ltd.
What is driving the Myopia Control market?
An ageing population, more people with diabetes and long-term conditions, better treatments and wider access to specialist care are driving the myopia Control market.
Who regulates Myopia Control in Singapore?
Medical devices must be registered with the Health Sciences Authority (HSA), except low-risk Class A devices. Source: Health Sciences Authority. Checked 14 Nov 2026.
How is healthcare paid for in Singapore?
MediShield Life gives basic health insurance to all citizens and permanent residents, alongside MediSave savings accounts. Source: CPF Board, MediShield Life. Checked 14 Nov 2026.
How much research is published on Myopia Control?
PubMed lists 1,160 papers on Myopia Control added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Get a free sample The table of contents and sample pages. No payment needed. Request sample Consult Us Questions about Myopia Control in Singapore? Our analysts can size it for your plan. Talk to us See the public data Health figures for every country, free. Open the Public Health Dashboard

From our blog

Eye Health Supplements: Screens, Ageing and Vision2.2 billion people have a vision impairment. One supplement formula has strong trial evidence, but only for a… From Melghat, With Hope: How a Tribal Region is Redefining Newborn CareLow-cost digital tools empower tribal nurses, cutting newborn deaths through innovation
Back to Catalogue
Keep exploring

Related Medical Devices reports in Singapore

See all
Same topic, other categories

Related on eye health and pediatric

See the topic